All In MedTech

Device Trial Radar · NCT07891247

Complementary Exercise-Based Therapy for Obstructive Sleep Apnea

Complementary Therapy for Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

May 6, 2025

Primary completion

May 7, 2026

Study completion May 8, 2026

Sponsor

Lead sponsor
bioROneAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 23, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 20 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized interventional study evaluates a complementary exercise-based therapy in adults with moderate-to-severe obstructive sleep apnea who are receiving continuous positive airway pressure (CPAP) therapy. A total of 24 participants are assigned to either a complementary rehabilitation program in addition to usual care or to usual care alone. The rehabilitation program is performed for 90 days and includes two approximately 45-minute sessions per day, combining physical exercise, breathing exercises, and cervical-postural rehabilitation. The study evaluates changes in the apnea-hypopnea index, nocturnal oxygen saturation, sleep fragmentation, daytime sleepiness, quality of life, psychological symptoms, cardiovascular and respiratory parameters, body mass index, and cervical spine alignment.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • Multimodal Exercise, Respiratory and Cervical-Postural Rehabilitation ProgramBehavioral

    A 90-day structured rehabilitation program including physical conditioning, neuromotor and postural exercises, cervical mobility and relaxation exercises, controlled breathing and respiratory-awareness techniques, and relaxation/body-awareness strategies. Participants continue prescribed CPAP and usual clinical care throughout the intervention.

  • Continuous Positive Airway Pressure (CPAP)Device

    Participants continue their prescribed home CPAP therapy and other clinically indicated usual care throughout the study period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Residual Apnea-Hypopnea Index (AHI) During CPAP TherapyTime frame: Baseline and Day 90

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinical Rehabilitation Hospital Iași

    Iași, Iaşi, Romania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.